Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement - FactEntry
Teva raises €4b in European bond offering - Globes
Teva Logistics Services BV 34353519
Teva amplía la emisión de pagarés de sostenibilidad a $5.000 millones
UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 20-F TEVA PHARMACEUTICAL INDUSTRIES LIMITED
printmgr file
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
XS2406607171 Institutional Ownership and Shareholders - Teva Pharmaceutical Finance Netherlands II BV
A1VQDB | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,625 % bis 15.10.2028 | finanzen.net
Pourquoi l'obligation Teva Pharmaceutical 3,15% 2026 bondit sur le marché secondaire | Investing.com
A1ZZHS | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,250 % bis 31.03.2023 | finanzen.net
EDM-Ahorro R FI
Most Active Foreign Bonds 11.10.2021 – Societe Generale, Andina de Fomento, Credit Real SAB de CV, Russian Railways, Teva Pharma, CRH, Aroundtown, Verizon – Financial Markets Blog
A1ZZHM | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,875 % bis 31.03.2027 | finanzen.net
Eurobonos: Teva Pharmaceutical Industries, 4.75% 9may2027, USD (US88167AAP66)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Teva Pharmaceutical Finance Netherlands II B.V. (Director) - Curaçao
Barcode No-Print Zone
Teva Pharmaceutical Industries Pharmaceutical Industry Teva Pharmaceuticals USA, Inc. Teva Canada Teva Pharmaceutical Finance Netherlands III B.V., PNG, 827x354px, Teva Pharmaceutical Industries, Biosimilar, Brand, Corporation, Generic Drug Download Free
Fourth Quarter 2019 Results
Teva Pharmaceutical Industries LTD | PDF | Generic Drug | American Depositary Receipt
Condensed Interim Unaudited Financial Statements for the six month period ended 31 May 2021
